Division of Gastroenterology, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI.
Division of Infectious Diseases, Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI.
Inflamm Bowel Dis. 2020 Oct 23;26(11):1748-1758. doi: 10.1093/ibd/izz335.
Ulcerative colitis (UC) carries an increased risk of primary and recurrent Clostridiodes difficile infection (rCDI), and CDI is associated with UC flares. We hypothesized that specific fecal microbial changes associate with UC flare and rCDI.
We conducted a prospective observational cohort study of 57 patients with UC and CDI, CDI only, and UC only. Stool samples were collected at baseline, at the end of antibiotic therapy, and after reconstitution for 16S rRNA sequencing. The primary outcomes were recurrent UC flare and rCDI. Logistic regression and Lasso models were constructed for analysis.
There were 21 (45.7%) patients with rCDI, whereas 11 (34.4%) developed UC flare. Patients with rCDI demonstrated significant interindividual (P = 0.008) and intraindividual differences (P = 0.004) in community structure by Jensen-Shannon distance (JSD) compared with non-rCDI. Two cross-validated Lasso regression models predicted risk of rCDI: a baseline model with female gender, hospitalization for UC in the past year, increased Ruminococcaceae and Verrucomicrobia, and decreased Eubacteriaceae, Enterobacteriaceae, Lachnospiraceae, and Veillonellaceae (AuROC, 0.94); and a model 14 days after completion of antibiotics with female gender, increased Shannon diversity, Ruminococcaceae and Enterobacteriaceae, and decreased community richness and Faecalibacterium (AuROC, 0.9). Adding JSD between baseline and post-treatment samples to the latter model improved fit (AuROC, 0.94). A baseline model including UC hospitalization in the past year and increased Bacteroidetes was associated with increased risk for UC flare (AuROC, 0.88).
Fecal microbial features at baseline and after therapy predict rCDI risk in patients with and without UC. These results may help risk stratify patients to guide management.
溃疡性结肠炎(UC)发生原发性和复发性艰难梭菌感染(rCDI)的风险增加,而 CDI 与 UC 发作有关。我们假设特定的粪便微生物变化与 UC 发作和 rCDI 相关。
我们对 57 例 UC 合并 CDI、单纯 CDI 和单纯 UC 患者进行了前瞻性观察队列研究。在基线、抗生素治疗结束时和重新定植后采集粪便样本进行 16S rRNA 测序。主要结局是 rCDI 后 UC 复发和 rCDI。构建逻辑回归和套索模型进行分析。
21 例(45.7%)患者发生 rCDI,11 例(34.4%)发生 UC 发作。与非 rCDI 相比,rCDI 患者的个体间(P=0.008)和个体内(P=0.004)的群落结构差异明显(Jensen-Shannon 距离,JSD)。两个交叉验证的套索回归模型预测 rCDI 风险:一个基于基线的模型,包括女性、过去 1 年因 UC 住院、瘤胃球菌科和疣微菌科增加、真杆菌科、肠杆菌科、毛螺菌科和韦荣球菌科减少(AUROC,0.94);另一个是抗生素治疗结束后 14 天的模型,包括女性、Shannon 多样性增加、瘤胃球菌科和肠杆菌科增加、群落丰富度和粪杆菌减少(AUROC,0.9)。将基线和治疗后样本之间的 JSD 添加到后一个模型中可以提高拟合度(AUROC,0.94)。一个包括过去 1 年 UC 住院和 Bacteroidetes 增加的基线模型与 UC 发作风险增加相关(AUROC,0.88)。
基线和治疗后粪便微生物特征可预测 UC 合并和不合并 CDI 患者的 rCDI 风险。这些结果可能有助于对患者进行风险分层,以指导治疗。